From Genotype to Functional Risk: A Multi-Omic Approach to Predicting Thiopurine and Methotrexate Co-Therapy-Induced Liver Injury. [PDF]
Pharmaceuticals (Basel)Molnár D, Reznik E, Porrogi P.
europepmc +1 more source
Reply to: an assessment of the cytochrome P450 2-hydroxyisoflavanone synthase (2-HIS) crystal structure. [PDF]
Commun BiolWang X, Pan H, Sagurthi SR, Dixon RA.
europepmc +1 more source
Pharmacogenetic Associations with Statin Regimen Modification, Intolerance, and Adverse Outcomes in Coronary Artery Disease Patients. [PDF]
Pharmaceuticals (Basel)Abdel-Latif R +6 more
europepmc +1 more source
The Genetic Polymorphisms of CYP2C9 and VKORC1 in the Saudi Population and Their Impact on Anticoagulant Management. [PDF]
Medicina (Kaunas)Al Hamad M.
europepmc +1 more source
Extrapyramidal and anticholinergic reactions in an adolescent patient: a case for pharmacogenetic consideration. [PDF]
Biochem Med (Zagreb)Žunić Išasegi I +7 more
europepmc +1 more source
Knockdown of RNA editing proteins reshapes the HepaRG transcriptome and pharmacogene expression. [PDF]
Sci RepCollins JM, Yu F, Zhang Y, Wang D.
europepmc +1 more source
Positioning siponimod and the post-treatment gap: the unmet needs of SPMS patients in Italian real-world practice. [PDF]
Ther Adv Neurol DisordZanghì A +14 more
europepmc +1 more source
Exploring the roles of cytochrome P450 enzymes and their inhibitors in cancers and non-neoplastic human diseases. [PDF]
Arch Pharm ResLee H, Kwon YJ, Chun YJ.
europepmc +1 more source
Understanding Pharmacokinetic-Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2024 to Better Manage the Risk of Drug Interactions With Concomitant Medications: A Review of Clinical Data From New Drug Applications. [PDF]
Curr Ther Res Clin ExpYu J +4 more
europepmc +1 more source